US › Healthcare

Scribe Therapeutics Inc. Common Stock (SCTX)

US · Healthcare · Biotechnology

$20.08-3.09%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$1.9M

Net profit

$-6.5M

EPS

$-3.84

EPS estimate

$-6.20

Net margin

-337.7%

EPS came in at -3.84 against a street estimate of -6.20 — a beat of 38.1%.

Key statistics

Market cap

$362.0M

Forward P/E

0.0

P/B

0.00

Book value

$-66.33

EPS (TTM)

$-3.84

52-week high

$39.60

52-week low

$13.50

50-day MA

$25.87

200-day MA

$25.25

Analyst view

Analysts rate Scribe Therapeutics Inc. Common Stock a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $57.00.

Shareholding

Insiders

10.70%

Institutions

54.48%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Scribe Therapeutics Inc. Common Stock — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.